While investors and executives in the health care products industry have not remained untouched by the COVID-19 pandemic, they have not been as surprised as people might assume about the situation that global economies now find themselves in, with the second or even third waves of coronavirus in full flow.
That is how Nooman Haque, managing director, life sciences and healthcare at Silicon Valley Bank (SVB), has viewed the 11 months since the pandemic